图表内容
Alnylam持续开发新型核酸药物技术平台
ESC+ Design: Improved Specificity
Bis. M: Single Chemical entity for
and Safety in Human
simultaneous silencing of two transcripts
Linker
RoversirIM: Tailored Control of rnai
Pharmacology by Rapid Reversal of
hepatic Delivery: RNAi Rx for
CNS and Ocular Disease
Target Silencing
源公司宫网
平安证券研究所
